Shanghai, China

Guoping Hu

USPTO Granted Patents = 32 

 

Average Co-Inventor Count = 8.1

ph-index = 3

Forward Citations = 24(Granted Patents)


Location History:

  • Nanjing, CN (2019)
  • Wuhan, CN (2020)
  • Dongguan, CN (2020)
  • Shanghai, CN (2018 - 2024)

Company Filing History:

goldMedal12 out of 65 
 
Medshine Discovery Inc.
 patents
silverMedal6 out of 118 
 
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
 patents
bronzeMedal5 out of 8 
 
Zhuhai United Laboratories Co., Ltd.
 patents
41 out of 31 
 
Cspc Zhongqi Pharmaceutical Technology (shijiazhuang) Co., Ltd.
 patents
51 out of 4 
 
Harbin Zhenbao Pharmaceutical Co., Ltd.
 patents
61 out of 5 
 
Hubei Bio-pharmaceutical Industrial Technological Institute Inc.
 patents
71 out of 5 
 
Shijiazhuang Sagacity New Drug Development Company, Ltd.
 patents
81 out of 13 
 
Guangdong Raynovent Biotech Co., Ltd.
 patents
91 out of 5 
 
Genfleet Therapeutics (shanghai) Inc.
 patents
101 out of 3 
 
Guangzhou Joyo Pharmatech Co., Ltd.
 patents
111 out of 5 
 
Luoxin Pharmaceutical (shanghai) Co., Ltd.
 patents
121 out of 6 
 
Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
 patents
131 out of 1 
 
Jumbo Drug Bank Co., Ltd.
 patent
141 out of 4 
 
Wuxi Fortune Pharmaceutical Co., Ltd
 patents
151 out of 3 
 
Fujian Cosunter Pharmaceutical Co., Ltd.
 patents
161 out of 2 
 
Changzhou Yinsheng Pharmaceutical Co., Ltd.
 patents
171 out of 235 
 
Sichuan University
 patents
181 out of 3 
 
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
 patents
191 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2018-2025

Loading Chart...
Loading Chart...
32 patents (USPTO):

Title: Guoping Hu: Pioneering Innovations in Pharmaceuticals

Introduction:

Guoping Hu, a visionary inventor hailing from Shanghai, China, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 27 patents, his groundbreaking work has been at the forefront of advancements in the treatment of various diseases.

Latest Patents:

1. Compound for use in retinal diseases: Guoping's innovative compound, designed as an aldehyde binder, shows promise in the treatment of retinal diseases. This patent represents a significant step forward in addressing ocular health.

2. [1,2,4]triazolo[1,5-a]pyridine compound as JAK inhibitor: Another notable patent by Guoping Hu involves a JAK inhibitor compound, crucial for developing drugs to target diseases associated with JAK1 or TYK2. This patent underscores his commitment to advancing therapies for challenging conditions.

Career Highlights:

Guoping Hu has left an indelible mark on the pharmaceutical industry, with stints at renowned companies such as Medshine Discovery Inc. and Chia Tai Tianqing Pharmaceutical Group Co., Ltd. His expertise and dedication have propelled these organizations towards excellence in drug discovery and development.

Collaborations:

Throughout his illustrious career, Guoping has had the privilege of collaborating with esteemed professionals in the field. Noteworthy among his coworkers are Jian Li and Shuhui Chen, whose collective efforts have led to groundbreaking innovations in the pharmaceutical sector.

Conclusion:

In conclusion, Guoping Hu's inventive spirit and tireless pursuit of excellence have solidified his position as a trailblazer in pharmaceutical research. His patents and collaborations stand as testaments to his unwavering commitment to advancing healthcare solutions, particularly in the realm of cutting-edge drug development for challenging diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…